Skip to main content
Fig. 1 | Trials

Fig. 1

From: Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial

Fig. 1

Inclusion and exclusion criteria. WHO, World Health Organization; UM, uveal melanoma; WBC, white blood cell; AST, aspartate aminotransferase; ULN, upper limit of normal; ALT, alanine aminotransferase; INR, international normalized ratio; PTT, partial thromboplastin time; LDH, lactate dehydrogenase; M-PHP, percutaneous hepatic perfusion with melphalan

Back to article page

Trials

ISSN: 1745-6215